Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1451 |
Slate Path Capital
New York
| $0 | -$6.75M | 0 | – | Closed |
|
| 1452 |
SSW
Smith Shellnut Wilson
Ridgeland,
Mississippi
| $0 | -$207K | 0 | – | Closed |
|
| 1453 |
SIG
Stanford Investment Group
Mountain View,
California
| $0 | -$15K | 0 | – | Closed |
|
| 1454 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
| $0 | -$1.5M | 0 | – | Closed |
|
| 1455 |
TA
TMD & Associates
Scottsdale,
Arizona
| $0 | -$2.44M | 0 | – | Closed |
|
| 1456 |
TFA
Transamerica Financial Advisors
St. Petersburg,
Florida
| $0 | -$1K | 0 | – | Closed |
|
| 1457 |
TI
Turner Investments
Berwyn,
Pennsylvania
| $0 | -$1.55M | 0 | – | Closed |
|
| 1458 |
Twin Tree Management
Dallas,
Texas
| $0 | -$2.5M | 0 | – | Closed |
|
| 1459 |
Wolverine Asset Management
Chicago,
Illinois
| $0 | -$118K | 0 | – | Closed |
|